enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Selexipag - Wikipedia

    en.wikipedia.org/wiki/Selexipag

    Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). [3] [4] Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. [5]

  3. Riociguat - Wikipedia

    en.wikipedia.org/wiki/Riociguat

    The drug was well tolerated and superior to NO in efficacy and duration. An open-label, non-controlled phase II trial of riociguat in 75 adult patients (42 with CTEPH and 33 with PAH, all in World Health Organization (WHO) functional class II or III) evaluated the safety and tolerability, and the effects on hemodynamics, exercise capacity and ...

  4. Sitaxentan - Wikipedia

    en.wikipedia.org/wiki/Sitaxentan

    Sitaxentan is a small molecule that blocks the action of endothelin (ET) on the endothelin-A (ET A) receptor selectively (by a factor of 6000 compared with the ET B). [3] It is a sulfonamide class endothelin receptor antagonist (ERA) and is undergoing Food and Drug Administration (FDA) review for treating pulmonary hypertension.

  5. Merck (MRK) Posts Positive Results From PAH Drug Study - AOL

    www.aol.com/news/merck-mrk-posts-positive...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Arena (ARNA) Out-Licenses Rights to PAH Drug, Stock Up 22%

    www.aol.com/news/arena-arna-licenses-rights-pah...

    Arena (ARNA) inks a deal to out-license global rights to its phase III candidate, ralinepag, to United Therapeutics. Shares of the company rally 22% following this news.

  7. Macitentan - Wikipedia

    en.wikipedia.org/wiki/Macitentan

    Macitentan, sold under the brand name Opsumit, is an endothelin receptor antagonist developed by Actelion and approved for the treatment of pulmonary arterial hypertension (PAH). [5] Macitentan is a dual endothelin receptor antagonist, meaning that it acts as an antagonist of two endothelin (ET) receptor subtypes, ET A and ET B . [ 5 ]

  8. Viagra: What It Treats & Its Side Effects ( Plus What It Was ...

    www.aol.com/lifestyle/viagra-treats-side-effects...

    Pulmonary arterial hypertension (PAH) is a serious condition that happens when the tiny vessels in your lungs narrow, resulting in high blood pressure. Normally, the pulmonary artery supplies ...

  9. Iloprost - Wikipedia

    en.wikipedia.org/wiki/Iloprost

    Iloprost, sold under the brand name Ventavis among others, is a medication used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon, frostbite, and other conditions in which the blood vessels are constricted and blood cannot flow to the tissues. [4] Iloprost is a prostacyclin mimetic. [1]